Nuveen Asset Management, LLC - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 38 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$254,000
+6.3%
34,958
+11.7%
0.00%
Q4 2020$239,000
-11.2%
31,290
+5.6%
0.00%
Q3 2020$269,000
+9.3%
29,618
+1.6%
0.00%
Q2 2020$246,000
+167.4%
29,146
+55.7%
0.00%
Q1 2020$92,000
-31.9%
18,7180.0%0.00%
Q4 2019$135,000
-33.2%
18,7180.0%0.00%
Q3 2019$202,000
-16.9%
18,7180.0%0.00%
Q2 2019$243,00018,7180.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,470,0000.65%
Orbimed Advisors 6,466,783$31,946,0000.54%
SAMLYN CAPITAL, LLC 798,566$3,945,0000.10%
ADAGE CAPITAL PARTNERS GP, L.L.C. 915,355$4,522,0000.01%
IHT Wealth Management, LLC 11,660$58,0000.01%
FIDUCIARY TRUST CO 37,998$188,0000.01%
FRANKLIN RESOURCES INC 700,000$3,458,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 13,700$68,0000.00%
Tower Research Capital LLC (TRC) 2,249$11,0000.00%
MANCHESTER FINANCIAL INC 200$1,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders